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Objective: Pregnancy is a period of considerable change
in blood pressure, with an early pregnancy decrease
followed by a late pregnancy rise. High blood pressure in
pregnancy is associated with adverse perinatal outcomes
for the mother and offspring. We aimed to define normal
ranges of blood pressure across gestation.
Methods: We used repeated antenatal blood pressure
measurements [median (interquartile range) 10 (9–11) per
woman] for 10 327 women. Multilevel models were used
to derive longitudinal reference ranges for SBP and DBP
from 12 to 40 weeks gestation for the whole cohort, for
women with normal pregnancies (without essential
hypertension or preeclampsia who delivered an
appropriate-size-for-gestational age infant at term)
and for subgroups of normal pregnancies defined by
different levels of maternal prepregnancy BMI, smoking
and parity.
Results: In normal pregnancies, the mean (95% reference
range) SBP and DBP for nulliparous women at 12 weeks
gestation were 112.1 (88.6–135.5) and 65.4 (48.9–81.9)
mmHg, and at 37 weeks were 116.0 (92.3–139.7) and
70.0 (52.2–87.9) mmHg, respectively. For every additional
10mmHg of blood pressure at 12 weeks, normal ranges
were 2–3mmHg higher across gestation. Reference ranges
for multiparous women were 1–2mmHg lower
throughout pregnancy. Stratified reference ranges were
higher for women in higher prepregnancy BMI categories,
and lower for smokers than for nonsmokers throughout
pregnancy.
Conclusion: Normal ranges for blood pressure vary with
gestation age and by maternal subgroups. Whole
population and stratified normograms could be used as a
reference to identify abnormal trajectories.
Keywords: Avon Longitudinal Study of Parents and
Children, blood pressure, longitudinal, pregnancy,
reference range
Abbreviations: ALSPAC, Avon Longitudinal Study of
Parents and Children; HDP, hypertensive disorder of
pregnancy; ISSHP, International Society for the Study of
Hypertension in Pregnancy; LGA, large for gestational age;
NHS, National Health Service; SGA, small for gestational
age
INTRODUCTION
A
round 10% of women experience some form of
hypertension during pregnancy [1,2], which may
be preexisting or pregnancy-induced. These preg-
nancies carry a greater risk of a range of adverse perinatal
outcomes, including maternal and foetal death [3–5], intra-
uterine growth restriction of the infant and preterm birth
[6–8]. However, pregnancy is a period of substantial change
in blood pressure, with an early pregnancy decrease fol-
lowed by a steep rise in the latter half of pregnancy [9,10].
There is evidence that, even among women without pre-
existing hypertension or preeclampsia [11], a greater
increase in blood pressure, and the maximum level
reached, are also associated with reduced foetal growth
[11,12].
Furthermore, the early-pregnancy level and the average
change in blood pressure have been found to differ by
maternal prepregnancy BMI, smoking and parity [10,13,14],
even among women who then experienced a healthy birth
outcome [10]. This would imply that different trajectories of
blood pressure may be healthy for different subgroups of
women. However, differences in blood pressure trajec-
tories by maternal age and education were much smaller
[10]. It is also plausible that the normal trajectory may
depend on the initial level of blood pressure, as a greater
increase is likely to be tolerable for a woman who begins
pregnancy with a relatively low blood pressure. Establish-
ing blood pressure reference ranges across pregnancy for
different subgroups of women, who do not experience
adverse health outcomes, may provide important infor-
mation about what is normal at different gestational ages
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for different women. These normal ranges could be useful
for the identification of women whose blood pressure is
deviating from a healthy trajectory before they cross the
high blood pressure threshold, and thus lead to earlier
detection of women at risk. Despite the clear importance
of blood pressure in pregnancy, to our knowledge, there
are currently no normal reference ranges to aid clinical
interpretation of the repeat antenatal monitoring that is
routinely carried out.
Our aim was to develop reference ranges for SBP and
DBP across pregnancy, firstly for all women regardless of
pregnancy outcome and then for women who have healthy
term pregnancies (without essential hypertension or pre-
eclampsia, resulting in a live birth of an appropriate-size-
for-gestational-age baby) in a large population-based pro-
spective cohort. We also divided the group of women who
had healthy term pregnancies into a low-risk and a high-risk
group on the basis of maternal characteristics and fitted
reference ranges that were stratified by parity, BMI, smok-
ing and early-pregnancy blood pressure in order to allow
for a different normal trajectory of blood pressure change
for different subgroups of women.
MATERIALS ANDMETHODS
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective cohort study investigating
the health and development of children. The study has
been described in full elsewhere [15] and the study website
contains details of available data at http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary. In brief,
pregnant women with an expected delivery date between
1 April 1991 and 31 December 1992 living in a defined area
of Avon, SouthWest England, were eligible for recruitment.
Ethical approval for the study was obtained from the
ALSPAC Law and Ethics Committee and from the National
Health Service (NHS) local ethics committee. In total, 14 541
women were enrolled and 13 678 had a singleton preg-
nancy resulting in a live birth. We excluded multiple
pregnancies, as these would have different patterns of
blood pressure change and there were insufficient numbers
to study these in detail. Thirteen thousand, four hundred
and sixty-one of the women had data abstracted from
obstetric records and 13 000 had at least one blood pressure
measurement during pregnancy. Of these, 10 327 had com-
plete data on all maternal characteristics.
Obstetric measurements
All SBP and DBP measurements that were taken as part of
routine antenatal care by midwives or obstetricians were
abstracted from the women’s obstetric records by six
trained research midwives. There was no between-midwife
variation in mean values of the data abstracted and error
rates were consistently less than 1% in repeated data entry
checks. These were single blood pressure measurements
taken in the seated position using the appropriate cuff size,
using Korotkoff phase V for DBP. The gestational age of
measurement was derived from the date of measurement
and the expected delivery date. Gestational age at delivery
was derived from the expected delivery date and the date of
birth. For most women, the expected delivery date was
based on the last menstrual period date, while for a small
proportion, this estimate was updated following an ultra-
sound scan. In the data abstracted from the clinical records,
it was not recorded which few women had a scan or had
their gestational age adjusted.
Birth size
The child’s birthweight was obtained from the birth noti-
fication. We defined small-for-gestational age (SGA) as
below the 10th percentile of birthweight for gestational
age and large-for-gestational age (LGA) as above the 90th
percentile of birthweight for gestational age within this
cohort by regressing birthweight on gestational age and
extracting the residuals.
Hypertension and diabetes before and during
pregnancy
Using all available blood pressure measurements, pre-
eclampsia was defined using the International Society for
the Study of Hypertension in Pregnancy (ISSHP) definition
as SBP at least 140mmHg and/or DBP at least 90mmHg as
well as proteinuria of 1þ or more on urine dipstick testing
on two occasions after 20 weeks gestation in a woman who
was not known to be hypertensive prior to pregnancy [16].
Women who responded to a questionnaire administered
during pregnancy that they had previously had hyperten-
sion outside of pregnancy were considered to have essen-
tial hypertension. Women who responded that they had
previously had diabetes outside of pregnancy were classed
as having existing diabetes, and for those without existing
diabetes, any diagnosis of gestational diabetes was
obtained from obstetric records.
Other maternal characteristics
Maternal prepregnancy weight, height, parity and smoking
status were obtained from questionnaires administered
during pregnancy. Prepregnancy BMI was calculated
as weight (kg)/height (m)2 and classed according to
WHO definitions of underweight (<18.5 kg/m2), normal
(18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and
obese (30.0 kg/m2). A questionnaire at 18 weeks gestation
asked about smoking status, which was categorized as
‘never during pregnancy’; ‘prepregnancy/first trimester’
for women who smoked immediately prior to pregnancy
or in the first 3 months and then stopped; or ‘throughout’ for
women who continued to smoke after the first 3 months.
Definition of normal pregnancy
To restrict to normal pregnancies, we excluded 515 (5.0%)
women who delivered preterm (<37 weeks gestation), 937
(9.1%) who had an SGA offspring, 1040 (10.1%) who had an
LGA offspring, 369 (3.6%) with preexisting hypertension,
213 (2.1%) who developed preeclampsia, 38 (0.4%) with
existing diabetes and 46 (0.4%) who developed gestational
diabetes (total excluded¼ 2823). We did not exclude
women who had gestational hypertension, as this would
have removed the top end of the blood pressure distri-
bution and biased reference ranges downwards. After
these exclusions, there remained 7504 women who had
a normal pregnancy.
Normal blood pressure ranges in pregnancy
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Statistical analysis
To develop longitudinal reference ranges for SBP and DBP
across gestation, we used multilevel models with two
levels: measurement occasions (level 1) within women
(level 2). These models take into account that the repeated
measurements of blood pressure within individuals are not
independent, and allow for varying numbers and timings of
measurements between women under a missing at random
assumption [17,18].
Separate multilevel models were fitted with SBP and
DBP as the outcome, respectively, and each had gestational
age as the exposure, assuming normal variation in the
population at each gestational age. Restricted cubic splines
with knots at 11, 18, 30, 36 and 40 weeks gestation were
used to describe the shape of the blood pressure trajectory
over gestation. Full information is provided in online
supplemental material (including the choice of knots).
The baseline gestational age was set at 12 weeks, as this
was the median time of the first antenatal measurement. In
addition to gestational age, the models included other
explanatory variables as described below, or were fitted
separately on certain subgroups of women to allow for
complexity in their trajectories. Ninety-five percent refer-
ence ranges for SBP and DBP from 12 to 40 weeks gestation
were then estimated from each fitted model.
We first fitted reference ranges for all women who had
complete data on all maternal characteristics, regardless of
pregnancy outcome. We then restricted to women who had
a normal pregnancy (see definition above). Finally, we
divided the women who had a normal pregnancy into
subgroups and fitted normal reference ranges for the
different subgroups.
The subgroups of interest were defined by the cross-
classification of BMI and smoking status. The ‘low-risk’
group comprised those who had normal prepregnancy
BMI and did not smoke either immediately prior to or
during pregnancy. The ‘high-risk’ group included women
who were overweight/obese and who smoked either
immediately prior to pregnancy or in the first trimester
only or who smoked throughout pregnancy. Further refer-
ence ranges were produced by prepregnancy BMI category
(including only those who never smoked) and by smoking
status (including only those with a normal prepregnancy
BMI). In order to predict blood pressure trajectories for the
entire duration of pregnancy from a single blood pressure
measure at 12 weeks, as would be available in a clinical
setting, reference ranges conditional on such possible val-
ues were developed for the low-risk group (see supple-
mental material, http://links.lww.com/HJH/A403) [19]. In
each of these analyses, separate models were fitted for
nulliparous and multiparous women. A full list of the
subgroups for whom reference ranges have been devel-
oped is given in Supplementary Table 1, http://links.
lww.com/HJH/A403.
As a sensitivity analysis, we refitted the reference ranges
in the low-risk group as defined when using the customized
foetal growth reference of Gardosi and Francis [20] to define
SGA and LGA. Reference ranges were not meaningfully
different from those presented here.
We used MLwiN version 2.27 to fit the multilevel models
that we ran through Stata using the runmlwin command [21].
The reference range figures were produced in R version
2.15.1. Stata version 12.1 (Stata Corp. College Station, Texas,
USA) was used for all other analyses.
RESULTS
The characteristics of women who had complete data for
inclusion in reference ranges and those that were excluded
from analysis due tomissing maternal characteristic data are
summarized in Table 1. Women who were included were
generally similar to those who were excluded, although
they were slightly more likely to be underweight. Women
whowere includedwho had normal pregnancies had lower
SBP and DBP at 12 and 37 weeks gestation and were less
likely to be overweight/obese, less likely to be nulliparous
and less likely to smoke throughout pregnancy than
women who were considered to have an abnormal preg-
nancy due to either a medical condition (essential hyper-
tension, preeclampsia, existing or gestational diabetes
N¼ 647) or an adverse perinatal outcome (preterm birth,
SGA or LGA offspring; N¼ 2404).
Figure 1 shows the reference ranges for SBP and DBP
between 12 and 40 weeks gestation for all women and for
those women who had a normal pregnancy, by parity. The
predicted values and 95% reference ranges at 12, 20 and 37
weeks gestation are summarized in Supplementary Table 2,
http://links.lww.com/HJH/A403. The reference ranges for
SBP and DBP decreased until mid-pregnancy in both nul-
liparous and multiparous women before rising until the end
of pregnancy, although the decrease was more pronounced
in multiparous women than in nulliparous women. The
average timing of the nadir in SBP varied, occurring at
17 weeks in nulliparous women and 18 weeks in multi-
parous women in the whole cohort and also when restrict-
ing to normal pregnancies. The nadir in DBP occurred at
around 19 weeks of gestation in nulliparous women and
20 weeks in multiparous women in the whole cohort and at
around 20 weeks for both nulliparous and multiparous
women when restricting to normal pregnancies. The 95%
reference range for SBP was approximately 45–50mmHg
wide and for DBP was approximately 30–35mmHg wide in
the whole cohort, both widening slightly towards the end of
gestation. Upper reference range limits were generally
slightly lower across gestation in normal pregnancies than
in the whole cohort but, as ranges were also slightly
narrower, the lower reference range limits were similar
in the whole cohort and in normal pregnancies.
Reference ranges in subgroups of normal
pregnancies
The reference ranges of SBP and DBP across gestation in
the low-risk group (normal prepregnancy BMI; never
smoked) and in the high-risk group (overweight/obese;
smoked at any time either immediately prior to or during
pregnancy) of women who had normal pregnancies are
shown in Fig. 2. Supplementary Table 2, http://link-
s.lww.com/HJH/A403 summarizes the predicted values
and 95% reference ranges of SBP and DBP at 12, 20 and
37 weeks gestation. Reference ranges in the high-risk group
were generally around 4mmHg higher than in the low-
risk group across pregnancy for both nulliparous and
Macdonald-Wallis et al.
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multiparous women. SBP for nulliparous women in the
high-risk group did not show a mid-pregnancy dip, but
increased throughout pregnancy.
Reference ranges stratified by maternal prepregnancy
BMI are shown for nulliparous nonsmoking women in
Fig. 3 and for multiparous women in Supplementary
Figure 1, http://links.lww.com/HJH/A403. For both nullipar-
ous and multiparous women, there was an increasing trend
in the limits of the reference ranges with increasing prepreg-
nancy BMI category at each gestational age. For example, for
nulliparous women, upper and lower reference range limits
of SBP were approximately 10mmHg higher throughout
pregnancy for obese than for normal weight women, and
for DBP were approximately 7.5–8mmHg higher (Supple-
mentary Table 2, http://links.lww.com/HJH/A403). The
shape of the blood pressure trajectory also differed by
prepregnancy BMI category (Supplementary Figures 2 and
3, http://links.lww.com/HJH/A403), with obese women
having a more distinct nadir in SBP and DBP than normal
weight women in the nulliparous group.
Reference ranges stratified by smoking during preg-
nancy are shown in Fig. 4 for nulliparous normal-weight
women and Supplementary Figure 4, http://links.
lww.com/HJH/A403 for multiparous women. SBP refer-
ence ranges were around 0–1.5mmHg lower across preg-
nancy for women who smoked throughout pregnancy than
for nonsmokers, while DBP reference ranges were around
1–2mmHg lower (Supplementary Table 2, http://links.
lww.com/HJH/A403). Those who smoked only prepreg-
nancy/first trimester had 1–2mmHg lower SBP and DBP
reference ranges in early pregnancy than nonsmokers, but
this difference attenuated towards the end of gestation. The
average SBP and DBP trajectories by smoking status are
shown in Supplementary Figures 5 and 6, respectively,
http://links.lww.com/HJH/A403.
Figure 5 shows the predicted reference ranges of SBP and
DBP across pregnancy, conditional on different possible
levels of bloodpressure at 12weeks gestation for nulliparous
women. The equivalent reference ranges for multiparous
women are shown in Supplementary Figure 7, http://links.
lww.com/HJH/A403. For each additional 10mmHg in SBP at
12 weeks, the reference ranges for SBP were predicted to be
approximately 4mmHg higher at 20 weeks and around
3mmHg higher at 37 weeks gestation in both nulliparous
and multiparous women (Supplementary Table 3, http://
links. lww.com/HJH/A403). For each additional 10mmHg in
DBP at 12 weeks, the reference ranges for DBP were pre-
dicted to be around 3mmHg higher at 20 weeks and around
2.5mmHg higher at 37 weeks (Supplementary Table 3,
http://links.lww.com/HJH/A403).
DISCUSSION
We have derived reference ranges for blood pressure from
12 to 40 weeks gestation in a large population-based
pregnancy cohort and compared these with reference
ranges for women who had a normal pregnancy, without
essential hypertension or preeclampsia, existing or gesta-
tional diabetes who delivered an appropriate-sized infant at
term. We found that normal pregnancies had generally
lower upper reference range limits and narrower reference
ranges throughout pregnancy. We also observed differ-
ences in reference ranges between different subgroups
of women with normal pregnancies based on prepreg-
nancy BMI, smoking and parity and found that the expected
normal trajectory of blood pressure differed by the blood
TABLE 1. Maternal characteristics of womenwhowere excluded from analysis due to incomplete data and of womenwhowere included
by pregnancy type
Pregnancies
without complete
data (N¼2673) Pregnancies with complete data
All (N¼10327)
Normal pregnancies
(N¼7504)
Maternal medical
condition or adverse
pregnancy outcome
(N¼2823)
N with
data
Mean
(SD) or % N Mean (SD) or % N Mean (SD) or % N Mean (SD) or %
Blood pressure
SBP at 12 weeks (mmHg) 2673 112.1 (12.77) 10327 112.1 (12.12) 7504 111.5 (11.83) 2823 113.7 (12.72)
DBP at 12 weeks (mmHg) 2673 65.7 (9.06) 10327 65.7 (8.56) 7504 65.2 (8.30) 2823 66.8 (9.13)
SBP at 37 weeks (mmHg) 2673 116.0 (13.21) 10327 116.0 (12.92) 7504 115.0 (12.22) 2823 118.8 (14.22)
DBP at 37 weeks (mmHg) 2673 70.0 (10.24) 10327 69.9 (9.71) 7504 69.0 (9.06) 2823 72.4 (11.42)
Number of measuresa [median (IQR)] 2673 10 (8, 11) 10327 10 (9, 11) 7504 10 (9, 12) 2823 10 (8, 11)
Parity
Nulliparous (%) 794 45.4 4718 45.7 3372 44.9 1346 47.7
Multiparous (%) 954 54.6 5609 54.3 4132 55.1 1477 52.3
Prepregnancy BMI
Underweight (%) 35 7.1 514 5.0 379 5.1 135 4.8
Normal weight (%) 351 71.2 7665 74.2 5703 76.0 1962 69.5
Overweight (%) 77 15.6 1566 15.2 1074 14.3 492 17.4
Obese (%) 30 6.1 582 5.6 348 4.6 234 8.3
Smoking in pregnancy
Never (%) 1044 55.8 7076 68.5 5176 69.0 1900 67.3
Prepregnancy/first trimester (%) 309 16.5 1373 13.3 1000 13.3 373 13.2
Throughout (%) 518 27.7 1878 18.2 1328 17.7 550 19.5
aThis is the number of blood pressure measurements per woman after randomly selecting one measure per 2-week period of pregnancy for use in the multilevel models.
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pressure at the first antenatal visit (in this cohort at around
12 weeks gestation). To our knowledge, there are no
existing longitudinal reference ranges for blood pressure
in normal pregnancy. The shape of the average trajectory of
blood pressure in pregnancy as decreasing until mid-preg-
nancy followed by an increase in late-pregnancy has been
well described [9,22,23], and the addition of normal ranges
to these average trajectories allows observed blood pres-
sure measurements at any gestational age to be compared
with expected limits.
This study benefits from its large size, repeated measure-
ments of blood pressure and detailed information on
maternal characteristics. The blood pressure measurements
were collected during routine clinical practice, and thus
will have greater measurement error than standardized
measures. However, this means that the reference ranges
are applicable to a clinical setting. The pregnancies
occurred approximately 20 years ago and levels of obesity
in the UK have increased over this period [24], although
smoking prevalence has reduced [25]. However, the
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FIGURE 1 Reference ranges for SBP and DBP between 12 and 40 weeks gestation in the full cohort with complete data (nulliparous N¼4718; multiparous N¼5609) and
in normal pregnancies only (nulliparous N¼3372; multiparous N¼4132). Centiles are labelled. A normal pregnancy was defined as one in which the woman did not have
essential hypertension, preeclampsia, existing or gestational diabetes and delivered an appropriate-for-gestational-age sized infant at term.
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analyses are stratified by BMI and smoking and these
changes are unlikely to have had a large effect on blood
pressure levels within strata. The ALSPAC participants also
differed slightly from the UK as a whole, being more likely
to live in owner-occupied accommodation and to have a car
and less likely to be nonwhite [15]. In the interests of space,
we have not presented reference ranges for all possible
subgroups of women, but have provided examples of low
and high-risk groups and demonstrated how reference
ranges differ with each of the maternal characteristics. This
approach could be extended to develop customized blood
pressure charts for all women based on prepregnancy BMI,
smoking, parity and first blood pressure measurement;
however, we did not have sufficient power to derive
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FIGURE 2 Reference ranges for systolic and diastolic blood pressure between 12 and 40 weeks gestation in low-risk (nulliparous N¼1832; multiparous N¼2193) and
high-risk (nulliparous N¼205; multiparous N¼285) normal pregnancies. Centiles are labelled. The low-risk group included women who had a normal prepregnancy BMI
and did not smoke either immediately prior to or during pregnancy. The high-risk group included overweight or obese women who smoked either immediately prior to
pregnancy, in the first trimester or throughout pregnancy.
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reference ranges for some of the smaller subgroups in the
present study. The graphs presented here are illustrative
and validation in other cohorts is required before these can
be used in clinical practice.
The differences in normal ranges between obese
and normal weight women of nearly 8–10mmHg in SBP
and nearly 6.5–8mmHg in DBP at each gestational age
are in line with the differences in average trajectories
found in our previous study in this cohort with weaker
exclusion criteria [10], in the Generation R study from the
Netherlands [13] and in the U.S.-based Omega Study [26].
The two studies in other cohorts, however, included
women with preeclampsia, preterm birth and SGA or
LGA offspring. The magnitude of the differences between
BMI categories may have important implications for
risk-related levels of high blood pressure for women of
different BMIs and at different gestational ages. For
example, for nulliparous obesewomen, values of SBP over
140mmHg were well within the 95% reference range
across the whole of pregnancy, whereas for normal weight
women, the 95% reference range remains below
135mmHg for much of pregnancy.
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Although smaller differences in blood pressure reference
ranges were seen between smoking groups (up to
2mmHg), they suggest that smoking status may be useful
to include, along with prepregnancy BMI, in prediction
models which use deviations from each woman’s expected
blood pressure trajectory to identify high-risk pregnancies.
In our previous study, we found strong statistical evidence
to support lower average blood pressure trajectories for
smokers than for nonsmokers [10], and other cohorts have
supported this finding for DBP, although findings relating
to SBP have been conflicting [9,14,27]. It has been shown
that blood pressure tracks moderately across pregnancy,
with almost 50% of women remaining in the same third of
blood pressure from the first trimester to the third trimester
[23], which supports the differences that we found in the
expected trajectories of blood pressure across pregnancy
by blood pressure levels at 12 weeks.
The diagnostic criteria for hypertensive disorders of
pregnancy (HDP) use the same blood pressure thresholds
of 140/90mmHg across the whole gestational period
between 20 weeks and delivery and for all women,
although nulliparous women, obese women and those
with high prepregnancy blood pressure are considered
to be at a high risk for HDP [28]. Our findings suggest
that using different blood pressure thresholds for diffe-
rent maternal subgroups to identify women whose blood
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FIGURE 4 Reference ranges for SBP and DBP by maternal smoking during pregnancy for nulliparous normal-weight women with normal pregnancies (N¼2654). Centiles
are labelled.
SBP of 100 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
150
140
130
120
110
100
90
80
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
(a)
DBP of 50 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
100
90
80
70
60
50
40
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
(e)
DBP of 60 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
100
90
80
70
60
50
40
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
(f)
DBP of 70 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
100
90
80
70
60
50
40
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
(g) (h)
DBP of 80 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
100
90
80
70
60
50
40
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
SBP of 110 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
150
140
130
120
110
100
90
80
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
(b)
SBP of 120 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
150
140
130
120
110
100
90
80
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
(c) (d)
SBP of 130 mmHg at 12 weeks
B
lo
od
 p
re
ss
ur
e 
(m
m
H
g
)
Gestational age (weeks)
150
140
130
120
110
100
90
80
12 16 20 24 28 32 36 40
97.5th
2.5th
95th
90th
5th
50th
10th
Systolic blood pressure
Diastolic blood pressure
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women with normal pregnancies (N¼1832). Centiles are labelled. Note that in each of the plots, there is a star that corresponds to the value of SBP/DBP at 12 weeks.
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pressure has deviated from the normal trajectory may
provide additional information about risk. Nevertheless,
subgroups of women who are known to be at a higher risk
of adverse perinatal outcomes should be considered as
such, even with blood pressure within the normal range.
Our reference ranges also show differences of around
5mmHg in SBP and DBP between 20 weeks and delivery,
suggesting that using different blood pressure thresholds at
different gestational agesmay improve the identification of
women with abnormal trajectories.
There has been much research in the area of foetal
growth charts [29–31], and more recently customized charts
that are dependent on maternal characteristics [20]. Routine
measurements of symphysis-fundal height and ultrasound
scan measurements of foetal size may be compared against
these charts and used to identify growth-restricted foetuses
[32,33]. There may be potential for blood pressure charts in
pregnancy to be used in conjunction with foetal growth
charts to aid in the identification of pregnancies at risk of
SGA infants, as high blood pressure and greater increases in
blood pressure are associated with reduced offspring birth-
weight [11,12]. In addition, blood pressure reference ranges
may help to identify womenwho are at risk of preeclampsia
and delivering preterm. We have previously shown in this
cohort [34] and others elsewhere [23] that the increase in
blood pressure is steeper in preeclamptic than in normo-
tensive pregnancies. Thus, preeclamptic women would be
expected to deviate from the normal pattern of change,
although the potential for deviations from the normal
trajectory to be used in prediction of adverse outcomes
remains to be assessed.
We conclude that the normal pattern of change in blood
pressure across gestation, for a healthy term pregnancy
resulting in an appropriate sized infant, differs by maternal
subgroups. There may be potential to use whole popu-
lation and stratified normal reference ranges such as these
in screening for women with abnormal trajectories, which
may be indicative of potential adverse pregnancy out-
comes such as preeclampsia, preterm birth and SGA off-
spring. However, the value of this will require evaluation
through the development and validation of prediction
models.
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